Heska Corporation
HSKA
$119.99
Share price
0.00%
Change (1 day)
29.80%
Change (1 year)
Categories
Heska Corporation (HSKA) - Cash on Hand
Cash on Hand as of March 2023 : $0.12 B
According to Heska Corporation
's latest financial reports the company has $0.12 B in cash and cash equivalents.
A company’s cash on hand also refered as cash/cash equivalents (CCE) and Short-term investments, is the amount of accessible money a business has.
Heska Corporation - Cash on Hand chart (from 2001 to 2023)
Cash on Hand by year
| Year | Cash on Hand | Change |
|---|---|---|
| 2022-12-31 | $0.15 B | -29.95% |
| 2021-12-31 | $0.22 B | 158.96% |
| 2020-12-31 | $86.33 M | -3.03% |
| 2019-12-31 | $89.03 M | 564.95% |
| 2018-12-31 | $13.38 M | 38.62% |
| 2017-12-31 | $9.65 M | -10.52% |
| 2016-12-31 | $10.79 M | 56.66% |
| 2015-12-31 | $6.89 M | 17.68% |
| 2014-12-31 | $5.85 M | -2.68% |
| 2013-12-31 | $6.01 M | 4.01% |
| 2012-12-31 | $5.78 M | -8.65% |
| 2011-12-31 | $6.33 M | 15.29% |
| 2010-12-31 | $5.49 M | 1.7% |
| 2009-12-31 | $5.4 M | 14.77% |
| 2008-12-31 | $4.7 M | -14.83% |
| 2007-12-31 | $5.52 M | 4.72% |
| 2006-12-31 | $5.27 M | 0.84% |
| 2005-12-31 | $5.23 M | 5% |
| 2004-12-31 | $4.98 M | 2.15% |
| 2003-12-31 | $4.87 M | -19.07% |
| 2002-12-31 | $6.02 M | 5.53% |
| 2001-12-31 | $5.71 M |
Cash on Hand for similar companies or competitors
| Company | Cash on Hand | differencediff. | Country |
|---|---|---|---|
 Novartis NVS | $13.96 B | 11,050.96% | 🇨🇭 Switzerland |
 Pfizer PFE | $12.69 B | 10,035.05% | 🇺🇸 USA |
 Eli Lilly LLY | $2.92 B | 2,238.25% | 🇺🇸 USA |
 IDEXX Laboratories IDXX | $0.45 B | 262.54% | 🇺🇸 USA |
 Zoetis ZTS | $2.03 B | 1,528.48% | 🇺🇸 USA |
 Merck MRK | $7.09 B | 5,564.93% | 🇺🇸 USA |
 Petco WOOF | $0.13 B | 11.64% | 🇺🇸 USA |